Sentences with phrase «product is in development»

Of course, we must note that patents are not always a sign that a product is in development.

At least one new NOOK device will be released for the coming holiday season and further products are in development.

«At least one new NOOK device will be released for the coming holiday season and further products are in development,» Michael Huseby, President of Barnes & Noble and CEO of Nook Media, said in the statement.

«At least one new NOOK device will be released for the coming holiday season and further products are in development» Huseby promised.

Both products are in development — HomeKit support isn't fully implemented yet — so it's likely that we won't see them on actual shelves for a few months.

Not exact matches

Schulz, who joined the exchange as a consultant in 2012, was put in charge of the product's development, which included lining up market makers and working on the specs.

According to the report, Foursquare is now back on track to beat sales expectations by the end of the year, and the business development team has been successful in attracting several new advertisers to their «post-check-in product.»

Ryan is a product manager at BizShark.com, with 5 years experience in online marketing and product development.

Both products featured in this episode are winners of a 2013 Edison Award, known around the world for recognizing and honoring innovation and excellence in the design, development, marketing and launch of new products and services.

Ryan is a Product Manager at BizShark.com, with 5 years experience in online marketing and product develProduct Manager at BizShark.com, with 5 years experience in online marketing and product develproduct development.

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

Founded in 2011, Innovent has built a portfolio of 16 potential products for treating cancer, autoimmune disorders and other diseases, and seven of those are in clinical development.

The purpose of the competitive analysis is to determine the strengths and weaknesses of the competitors within your market, strategies that will provide you with a distinct advantage, the barriers that can be developed in order to prevent competition from entering your market, and any weaknesses that can be exploited within the product development cycle.

The Edison Awards are known around the world for recognizing and honoring innovation and excellence in the design, development, marketing and launch of new products and services.

Any mistakes in your rollout's timing will hurt your budget and your reputation, so be realistic about lead times for product development, testing, quality assurance, commercialization, marketing and distribution.

We were in a board meeting for one of our EdTech companies and talking about the usual KPIs and basic business stuff and about how various aspects of the company's product development and enhancement efforts were progressing — especially how quickly we were moving to bring some of these new and critical features to market.

The Edison Awards ® are among the most prestigious accolades honoring excellence in new product and service development, marketing, human - centered design and innovation.

I joke that my unofficial title is «chief taste officer,» as I love to participate in the flavor and product development process.

An offshoot of the larger development firm Edison Nation, which has commercialized hundreds of products in its history, Edison Nation Medical is designed to address the overwhelming obstacles unique to the medical device industry.

However, by supporting artist communities and artists in residence at their facilities, Kohler is able to see how people engage in the development and design process of their products, and are able to better understand how to connect with the consumer.

Invest in product development, as well as your customer service efforts, and you'll likely find that your team performance improves, since they're selling a product they believe in.

Certain matters discussed in this news release are forward - looking statements that involve a number of risks and uncertainties including, but not limited to, doubts about the Company's ability to continue as a going concern, the need to obtain additional funding, risks in product development plans and schedules, rapid technological change, changes and delays in product approval and introduction, customer acceptance of new products, the impact of competitive products and pricing, market acceptance, the lengthy sales cycle, proprietary rights of the Company and its competitors, risk of operations in Israel, government regulations, dependence on third parties to manufacture products, general economic conditions and other risk factors detailed in the Company's filings with the United States Securities and Exchange Commission.

Gen 2 was jointly designed by product development teams in New York and Eisfeld and crafted by German engineers, with each feature influenced by Harry's customers.

These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.

We might be one of the smallest subsidiaries, with 20 - some people at the head office and 60 - some people across the country, versus something like 1,200 in the U.S.. We're not involved in product development at all or in the management of licensing, so we don't work with third - party software developers or even license merchandise goods like T - shirts and stuff like that.

In 2009, McCain removed unfamiliar and unpronounceable ingredients from its products as part of the company's «It's all good» commitment, which cost more than $ 10 million in research and developmenIn 2009, McCain removed unfamiliar and unpronounceable ingredients from its products as part of the company's «It's all good» commitment, which cost more than $ 10 million in research and developmenin research and development.

He was mainly in charge of financing and product development.

He says the product has been a year in the development.

That's the recommendation of Diane Vincent, a senior editor at Exam Master Corp., a publisher of medical - study tools in Middletown, Del. «Although our products were still in the development stage, we attended two fairs this past year: first a small one in Wilmington, and then the larger Mid-Atlantic Venture Fair, in Philadelphia,» she explains.

This investment was in training, coaching, personal development products and specialized consultants, all of which ensured that our internal capability kept growing at the same pace as our big client.

Factors which could cause actual results to differ materially from these forward - looking statements include such factors as the Company's ability to accomplish its business initiatives, obtain regulatory approval and protect its intellectual property; significant fluctuations in marketing expenses and ability to achieve or grow revenue, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission.

The resulting cup is rich, nuanced and unlike anything we've tasted before,» Jennifer Galbraith, Starbucks manager of product development for R&D said in a statement.

The money will be used for product development and field trials to shrink down the technology to chip size so it works in mobile phones and Wi - Fi devices.

When we see products or developments or large companies that are solving a problem in a new way, that drives M&A interest.

Gauge user reactions early on and save time in development by heading off concerns and building out features people like so that when the product actually comes to fruition it's better situated to garner rave reviews.

«New smartphones will definitely entice people to upgrade, but vendors are more careful of avoiding oversupply in the channel,» he said, adding that the market could see «a short period of stagnancy» as players refocused on research and development efforts instead of marketing products.

Shradha is focused on product innovation, scaling operations and talent development to cultivate ContextMedia's award - winning culture and industry leadership in technology entrepreneurship.

We're a Research & Development institution that produces a high - quality product — it just happens to be educational in nature.

Alder is additionally evaluating ALD1910, a preclinical product candidate also in development as a migraine prevention therapy.

Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.

For example, it was in a SWOT meeting that the product development director of my company, who was in his late twenties at the time, suggested that one of my company's weaknesses was my messing with the software code instead of just being the president.

These are norms that have developed over time in design - oriented organizations, or in the Scrum process [which emphasizes the importance of a flexible, non-traditional strategy for managing software product development].

Skunk works differed from advanced research groups in that they were more than just product development groups.

An unspecified product Patagonia is making with Bolt Threads is «still in development.»

That's the responsibility of their in - house product development team.

I'm eager to apply DARPA - style development to building hardware products at Facebook - audacious science and product development in one place?

My first marketing role was in product development.

While the metrics on the white board are different, Coach Dave's words remain eternal: energy (number of hours worked of overtime), effort (percentage of new product developments and revenue streams created by non-Bauer family staff) and desperation (the proportion of our overhead to sales, or how efficient we are in utilizing our capital and labor in our hungry quest for higher profit margins) remain an integral part of the winning formula.

Competitive analysis: The purpose of the competitive analysis is to determine the strengths and weaknesses of the competitors within your market, strategies that will provide you with a distinct advantage, the barriers that can be developed in order to prevent competition from entering your market, and any weaknesses that can be exploited within the product development cycle.

Although both product lines are in the late stages of their development (Bombardier obtained the permit for the Learjet 85's first test flight in February), they both follow the CSeries jet in the company's release queue.